Avastin for PDR (Proliferative Diabetic Retinopathy) (PDR)
Effect of Pre-operative Adjunctive Anti-VEGF on Growth Factors in Severe Proliferative Diabetic Retinopathy Requiring Surgical Management
Sponsor: University of Southern California
This NA trial investigates Diabetic Retinopathy and Retinal Detachment and is currently completed. University of Southern California leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Sep 2017 — Jun 2018 [monthly]
Completed NA
-
Feb 2017 — Sep 2017 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .